Lipid Controls
Cayman Chemical Lyso-PAF C-18 25mg
Lyso-PAF C-18 can be formed by either the action of PAF-AH on PAF C-18{2626} or by the action of a CoA-independent transacylase on 1-O-octadecyl-2-acyl-glycerophosphocholine.{240,2098} Lyso PAF C-18 is a substrate for eitherPAF C-18 formation by the remodeling pathway{939} or selective acylation with arachidonic acid by a CoA-independent transacylase.{2101}
Cayman Chemical Lyso-PAF C-16 25mg
Lyso-PAF C-16 can be formed by either the action of PAF-AH on PAF C-16,{2626} or by the action of a CoA-independent transacylase on 1-O-hexadecyl-2-acyl-glycerophosphocholine.{240,2098} Lyso-PAF C-16 is a substrate for either PAF C-16 formation by the remodeling pathway{939} or selective acylation with arachidonic acid by a CoA-independent transacylase.{2101}
![eMolecules Broadpharm / BP Lipid 122 / 50mg / 672542490 / BP-26379 / 95.000 / / [null] / 654.074 / C40H79NO5](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502480234.JPG-250.jpg)
eMolecules Broadpharm / BP Lipid 122 / 50mg / 672542490 / BP-26379 / 95.000 / / [null] / 654.074 / C40H79NO5
Broadpharm / BP Lipid 122 / 50mg / 672542490 / BP-26379 / 95.000 / / [null] / 654.074 / C40H79NO5
Avanti Polar Lipids 18:1 PI(4,5)P2 | 799268-56-7 | MFCD22416812 | 100 ug
18:1 PI(4,5)P2 | Purity: 99% | Mol Wt: 1073.569 | 799268-56-7 | MFCD22416812 | 100 ug
![eMolecules Broadpharm / PTPC / 25mg / 718091956 / BP-28326 / / 84271-00-1 / [null] / 824.178 / C47H86NO8P](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502474712.JPG-250.jpg)
eMolecules Broadpharm / PTPC / 25mg / 718091956 / BP-28326 / / 84271-00-1 / [null] / 824.178 / C47H86NO8P
Broadpharm / PTPC / 25mg / 718091956 / BP-28326 / / 84271-00-1 / [null] / 824.178 / C47H86NO8P
Medchemexpress LLC DSPE-PEG2000-cRGD | 96.2% | 2000 | 25 MG
DSPE-PEG2000-cRGD is a PEG compound composed of DSPE and an αvβ3 targeting peptide (cRGD). The cRGD peptide specifically binds to αvβ3 on the surface of many cancer cells and neovascular cells. It can be used for drug delivery.
- Composed of DSPE and an αvβ3 targeting peptide (cRGD)
- cRGD peptide specifically binds to αvβ3 on the surface of many cancer cells and neovascular cells
- Can be used for drug delivery
- Can be used to construct pp-siRNA/CLD/DNCA/DSPE-PEG2000-cRGD (PCNR) nanoparticles that specifically target tumor cells that highly express integrin αvβ3
- Incorporating it into liposomes can form spatially stable and integrin-targeting liposomes
- Can be used to construct C-siRNA/MTSLR-U and C-siRNA/MTSLR, which have anti-hepatocellular carcinoma activity
eMolecules Broadpharm / 1-Palmitoyl-2-Oleoyl-sn-glycero-3-PA / 1mg / 779524049 / BP-29569 / / 62600-81-1 / MFCD05864230 / 674.941 / C37H71O8P
Broadpharm / 1-Palmitoyl-2-Oleoyl-sn-glycero-3-PA / 1mg / 779524049 / BP-29569 / / 62600-81-1 / MFCD05864230 / 674.941 / C37H71O8P
Avanti Polar Lipids 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(6-azidohexanoyl) (ammonium salt), 2252461-34-8, 25 mg
Formula Weight: 848.145, Purity >99%, Storage Temperature: -20°C. This reagent is a modified lipid containing an omega-terminal azide. The terminal azide group can be used in a highly specific linking reaction with alkyne-containing reagents, known as ‘click chemistry’, in the presence of a copper (Cu)-containing catalyst.
Avanti Polar Lipids 1 2-DIOLEOYL-3-TRIMETHYLAMMONI
1,2-dioleoyl-3-trimethylammonium-propane (chloride salt). 132172-61-3
Cayman Chemical 1 3DIoctnoyl2Oleoyl Glyce 1mg
A triacylglycerol; reduces total cholesterol levels in both the plasma and aorta in a diet-induced hamster model of hypercholesterolemia
Cayman Chemical 1 3DIoleoyl2Decnoyl Glyce 5mg
A triacylglycerol; has been found in transitional human milk